Lactitol
As of the edition of 20 October 2026, Lactitol is a small molecule: marketed, first approved in 1985 (CH).
Sources: FDA Orange Book and Purple Book, other approval registers, ClinicalTrials.gov, ChEMBL.
The drug
- Status
- Marketed; latest approval 2020
- Kind
- Small molecule
- Brand name
- Pizensy
- First approved
- 3 September 1985 (CH)
- Approvals on record
- 4 in 4 regions
- Holder of the most recent approval
- Braintree; 4 holders in all
- Registered trials
- 3, 1 stopped early
- Disease areas
- Digestive system; Nutrition and metabolism
US protection
No US approval on record.
With no US approval on record there are no listed US patents or exclusivities.
This is the US only.
Registered trials
| Phase | Trials | Completed | Active | Stopped early |
|---|---|---|---|---|
| Phase not stated | 2 | 1 | 0 | 1 |
| Phase 2 | 1 | 0 | 0 | 0 |
| All trials | 3 |
Who has held its approvals
| Company | Role | Years |
|---|---|---|
| Braintree | Applicant | 2020 to now |